SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition
In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy
SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell.
Q1 2026 Financial Highlights
April 2026 E-Commerce Momentum
Recent Operational and Strategic Highlights
Management Commentary
"SenesTech is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the growing demand for non-poison rodent management solutions," said Michael Edell, Chief Executive Officer of SenesTech. "The strategic transition to directly managing our Amazon business and revamping our online e-commerce store has significantly improved our visibility into customer behavior, advertising performance, subscriptions, and overall channel economics. We are already seeing strong momentum in our direct-to-consumer business, particularly through accelerating subscription adoption and improved Amazon execution."
Mr. Edell continued, "Our efforts across Amazon, Shopify, packaging redesign, digital media buying, subscriptions, and customer engagement are all connected initiatives intended to reduce friction, improve conversion, increase customer retention, and create a stronger recurring revenue foundation. At the same time, we remain focused on improving operational discipline, maintaining strong gross margins and positioning the Company for scalable long-term growth."
"Our first quarter results reflected the expected temporary disruption associated with transitioning Amazon operations in-house, however the underlying consumer demand trends and April proof points were highly encouraging," said Tom Chesterman, Chief Financial Officer of SenesTech. "Direct-to-consumer revenue increased 42% to a record $194,000 during Q1, gross margin expanded to a Company record 68.6%, and subscription-based sales continued to accelerate breaking past revenue numbers. We believe these trends support the long-term strategic value of directly controlling our e-commerce channels and building a more predictable recurring revenue mix."
Use of Non-GAAP Measure
Adjusted EBITDA and Adjusted Net Loss are non-GAAP measures. However, these measures are not intended to be a substitute for those financial measures reported in accordance with GAAP. These measures have been included because management believes that, when considered together with the GAAP figures, they provide meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar term. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.
Conference Call Details
Date: Tuesday, May 12, 2026.
Time: 5:00 p.m. ET.
Webcast: https://app.webinar.net/m976bqQblKE.
Webcast Replay: Available for 90 days on the Company's website.
About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, statements regarding the acceleration of the Company's direct-to-consumer and e-commerce initiatives, the recurring nature of the Company's growing director-to-consumer business model, any growth attributable to the appointment of the Company's new CEO, the Company's efforts in driving B2B revenues, any increases in conversion rates and subscription growth, and any international expansion opportunities for the Company.
Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; regulatory approval and regulation of our products; challenges transitioning to direct management of Amazon sales of Evolve products or the results of such direct management not being as expected; having to use cash at times and in ways other than as planned; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, [email protected]
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143
SENESTECH, INC.
BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)
March 31,
2026
December 31,
2025
ASSETS
Current assets:
Cash and cash equivalents
$ 6,804
$ 7,575
Short-term investments
—
994
Accounts receivable, net
163
201
Inventory
1,048
994
Prepaid expenses and other current assets
338
297
Total current assets
8,353
10,061
Right to use asset, operating lease
2,295
2,336
Property and equipment, net
379
410
Other noncurrent assets
36
36
Total assets
$ 11,063
$ 12,843
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$ 115
$ 183
Accrued expenses
593
383
Current portion of operating lease liability
142
139
Current portion of notes payable
63
61
Deferred revenue
25
32
Total current liabilities
938
798
Operating lease liability, less current portion
2,296
2,332
Notes payable, less current portion
128
145
Total liabilities
3,362
3,275
Stockholders' equity:
Common stock
5
5
Additional paid-in capital
152,239
152,043
Accumulated deficit
(144,543)
(142,480)
Total stockholders' equity
7,701
9,568
Total liabilities and stockholders' equity
$ 11,063
$ 12,843
SENESTECH, INC.
STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended
March 31,
2026
2025
Revenues, net
$ 493
$ 485
Cost of sales
155
172
Gross profit
338
313
Operating expenses:
Research and development
422
418
Selling, general and administrative
2,035
1,558
Total operating expenses
2,457
1,976
Loss from operations
(2,119)
(1,663)
Interest income (expense), net
56
(2)
Net loss
$ (2,063)
$ (1,665)
Weighted average shares outstanding — basic and diluted
5,263,717
1,299,971
Loss per share — basic and diluted
$ (0.39)
$ (1.28)
SENESTECH, INC.
Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP)
(In thousands)
(Unaudited)
Three Months Ended
March 31,
2026
2025
Net loss (as reported, GAAP)
$ (2,063)
$ (1,665)
Non-GAAP adjustments:
Severance costs
230
27
One-time legal costs
213
45
Interest income, net
(56)
2
Stock-based compensation expense
23
91
Depreciation expense
31
39
Non-cash operating lease expense
8
—
Total non-GAAP adjustments
449
204
Adjusted EBITDA loss (non-GAAP)
$ (1,614)
$ (1,461)
SenesTech Inc.
Reconciliation of Net Loss and Adjusted Net Loss (non-GAAP)
(In thousands)
(Unaudited)
Three Months Ended
March 31,
Percent
Change
2026
2025
Net loss (as reported, GAAP)
$ (2,063)
$ (1,665)
24 %
Non-GAAP adjustments:
Severance costs
230
27
One-time legal costs
213
45
Adjusted net loss (non-GAAP)
$ (1,620)
$ (1,593)
2 %
SOURCE SenesTech, Inc.